Canagliflozin attenuates thioacetamide-induced liver injury through modulation of HMGB1/RAGE/TLR4 signaling pathways.
暂无分享,去创建一个
[1] G. Schiattarella,et al. Canagliflozin and myocardial oxidative stress: SGLT1 inhibition takes centre stage. , 2021, European heart journal.
[2] M. Karck,et al. The Sodium-Glucose Cotransporter-2 Inhibitor Canagliflozin Alleviates Endothelial Dysfunction Following In Vitro Vascular Ischemia/Reperfusion Injury in Rats , 2021, International journal of molecular sciences.
[3] N. Younis,et al. RETRACTED ARTICLE: Taurine ameliorates thioacetamide induced liver fibrosis in rats via modulation of toll like receptor 4/nuclear factor kappa B signaling pathway , 2021, Scientific Reports.
[4] C. Miao,et al. Sevoflurane Postconditioning Attenuates Hepatic Ischemia-Reperfusion Injury by Limiting HMGB1/TLR4/NF-κB Pathway via Modulating microRNA-142 in vivo and in vitro , 2021, Frontiers in Pharmacology.
[5] Sahar S. Abd El-Rahman,et al. Promoted inhibition of TLR4/miR-155/ NFkB p65 signaling by Cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide. , 2021, Chemico-biological interactions.
[6] Bin Liu,et al. Sphingosine kinase 1 regulates HMGB1 translocation by directly interacting with calcium/calmodulin protein kinase II-δ in sepsis-associated liver injury , 2020, Cell Death & Disease.
[7] J. Hermanides,et al. Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells , 2020, Cardiovascular Drugs and Therapy.
[8] Farzana Zerin,et al. Canagliflozin ameliorates renal oxidative stress and inflammation by stimulating AMPK–Akt–eNOS pathway in the isoprenaline-induced oxidative stress model , 2020, Scientific Reports.
[9] Farzana Zerin,et al. Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways , 2020, Scientific Reports.
[10] X. Xia,et al. Kaempferol from Penthorum chinense Pursh suppresses HMGB1/TLR4/NF-κB signaling and NLRP3 inflammasome activation in acetaminophen-induced hepatotoxicity. , 2020, Food & function.
[11] Xiangcheng Zhang,et al. HMGB1 mediates acute liver injury in sepsis through pyroptosis of liver macrophages. , 2020, International journal of burns and trauma.
[12] Z. Dong,et al. Canagliflozin reduces cisplatin uptake and activates Akt to protect against cisplatin-induced nephrotoxicity. , 2020, American journal of physiology. Renal physiology.
[13] H. Yoshiji,et al. Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis , 2020, International journal of molecular sciences.
[14] Der-Shan Sun,et al. Thioacetamide-induced liver damage and thrombocytopenia is associated with induction of antiplatelet autoantibody in mice , 2019, Scientific Reports.
[15] H. Fayed,et al. Targeting AngII/AT1R signaling pathway by perindopril inhibits ongoing liver fibrosis in rat , 2019, Journal of tissue engineering and regenerative medicine.
[16] A. K. A. Abdel Latif,et al. Effect of Canagliflozin, an SGLT2 Inhibitor, in Comparison with Atorvastatin on Dexamethasone-Induced Hepatic Steatosis in Albino Rats , 2019 .
[17] Y. Aso,et al. The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma , 2019, International journal of molecular sciences.
[18] Luwen Wang,et al. Protective role of AGK2 on thioacetamide-induced acute liver failure in mice. , 2019, Life sciences.
[19] M. Murphy,et al. The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion. , 2019, Biochimica et biophysica acta. Molecular basis of disease.
[20] O. Kim,et al. The Role of Phospho-c-Jun N-Terminal Kinase Expression on hepatocyte Necrosis and Autophagy in the Cholestatic Liver. , 2019, The Journal of surgical research.
[21] Samaneh Noroozi,et al. A Review on the Structure and Function of Liver from Avicenna Point of View and Its Comparison with Conventional Medicine , 2019, Traditional and Integrative Medicine.
[22] P. Kamath,et al. Burden of liver diseases in the world. , 2019, Journal of hepatology.
[23] A. Shalaby,et al. Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on cisplatin-induced nephrotoxicity in mice , 2018, Naunyn-Schmiedeberg's Archives of Pharmacology.
[24] N. Nieto,et al. High‐Mobility Group Box‐1 and Liver Disease , 2018, Hepatology communications.
[25] Soad L Kabil,et al. Canagliflozin protects against non‐alcoholic steatohepatitis in type‐2 diabetic rats through zinc alpha‐2 glycoprotein up‐regulation , 2018, European journal of pharmacology.
[26] T. Palmer,et al. Canagliflozin inhibits interleukin-1β-stimulated cytokine and chemokine secretion in vascular endothelial cells by AMP-activated protein kinase-dependent and -independent mechanisms , 2018, Scientific Reports.
[27] K. Tsuchiya,et al. Canagliflozin, an SGLT2 inhibitor, attenuates the development of hepatocellular carcinoma in a mouse model of human NASH , 2018, Scientific Reports.
[28] J. Wan,et al. Glycyrrhetinic acid prevents acetaminophen‐induced acute liver injury via the inhibition of CYP2E1 expression and HMGB1‐TLR4 signal activation in mice , 2017, International immunopharmacology.
[29] Y. Tajima,et al. HMGB1 is a promising therapeutic target for acute liver failure , 2017, Expert review of gastroenterology & hepatology.
[30] O. Dirsch,et al. Carbon monoxide ameliorates hepatic ischemia/reperfusion injury via sirtuin 1‐mediated deacetylation of high‐mobility group box 1 in rats , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[31] R. Venkataramanan,et al. Drug Metabolism in the Liver. , 2017, Clinics in liver disease.
[32] Yi-Bing Hu,et al. Correlation between high mobility group box-1 protein and chronic hepatitis B infection with severe hepatitis B and acute-on-chronic liver failure: a meta-analysis. , 2016, Minerva medica.
[33] P. Sil,et al. Silymarin Protects Mouse Liver and Kidney from Thioacetamide Induced Toxicity by Scavenging Reactive Oxygen Species and Activating PI3K-Akt Pathway , 2016, Front. Pharmacol..
[34] M. R. Talluri,et al. Thioacetamide-induced acute liver toxicity in rats treated with Balanites roxburghii extracts , 2016 .
[35] 7. Approaches to Glycemic Treatment , 2015, Diabetes Care.
[36] Lei Dong,et al. Protective effects of pentoxifylline on acute liver injury induced by thioacetamide in rats. , 2015, International journal of clinical and experimental pathology.
[37] K. Kodys,et al. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat–cholesterol–sugar diet model in mice , 2015, Journal of Translational Medicine.
[38] S. Friedman,et al. Standard Operating Procedures in Experimental Liver Research: Thioacetamide model in mice and rats , 2015, Laboratory animals.
[39] S. Yamagishi,et al. Role of receptor for advanced glycation end products (RAGE) in liver disease , 2015, European Journal of Medical Research.
[40] S. Reddy,et al. Reactive oxygen species in inflammation and tissue injury. , 2014, Antioxidants & redox signaling.
[41] Wen Hou,et al. Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases , 2013, Molecular Medicine.
[42] U. Moens,et al. The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation , 2013, Genes.
[43] J. Wendon,et al. Acute liver failure. , 2013, The New England journal of medicine.
[44] Sheng Liu,et al. High-Mobility Group Box-1 Induces Proinflammatory Cytokines Production of Kupffer Cells through TLRs-Dependent Signaling Pathway after Burn Injury , 2012, PloS one.
[45] B. Rajkapoor,et al. Protective effect of Pisonia aculeata on thioacetamide induced hepatotoxicity in rats. , 2012, Asian Pacific journal of tropical biomedicine.
[46] Mitchell R. McGill,et al. Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity. , 2012, Journal of hepatology.
[47] J. González‐Gallego,et al. Role of Quercetin in Preventing Thioacetamide-Induced Liver Injury in Rats , 2011, Toxicologic pathology.
[48] J. A. Nogueira-Machado,et al. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation , 2011, Expert opinion on therapeutic targets.
[49] I. N. Crispe,et al. TLRs in Hepatic Cellular Crosstalk , 2010, Gastroenterology research and practice.
[50] A. Coyle,et al. HMGB1 and RAGE in inflammation and cancer. , 2010, Annual review of immunology.
[51] A. Higure,et al. Recombinant human soluble thrombomodulin decreases the plasma high-mobility group box-1 protein levels, whereas improving the acute liver injury and survival rates in experimental endotoxemia , 2009, Critical care medicine.
[52] M. Uysal,et al. Role of carnosine in preventing thioacetamide-induced liver injury in the rat , 2008, Peptides.
[53] Arjan W. Griffioen,et al. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1) , 2008, Angiogenesis.
[54] A. Cuenda,et al. p38 MAP-kinases pathway regulation, function and role in human diseases. , 2007, Biochimica et biophysica acta.
[55] E. Abraham,et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. , 2006, American journal of physiology. Cell physiology.
[56] M. Bianchi,et al. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation , 2004, The Journal of cell biology.
[57] Hong Wang,et al. Structural Basis for the Proinflammatory Cytokine Activity of High Mobility Group Box 1 , 2003, Molecular medicine.
[58] J. Youngson,et al. Comparison of different scoring systems for immunohistochemical staining. , 1999, Journal of clinical pathology.
[59] J. Guesdon,et al. The use of avidin-biotin interaction in immunoenzymatic techniques. , 1979, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[60] K. Yagi,et al. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.
[61] S. Marklund,et al. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. , 1974, European journal of biochemistry.
[62] G. Ellman,et al. Tissue sulfhydryl groups. , 1959, Archives of biochemistry and biophysics.